How to Browse Peptide Profiles by Category on PeptaHub
Updated
PeptaHub organizes its peptide reference into 10 categories and 7 editorial hubs, so you can jump straight to a use case — recovery, weight loss, longevity, immune, skin & beauty, muscle & growth, GH secretagogues, or nootropics — instead of searching compound by compound. Start from the category or hub entry on the homepage if you already know what you're researching; use "Browse all 156 profiles" if you want the full directory.
The category structure
PeptaHub's compendium covers 156 profiles across 10 categories, sourced from 500+ references. The homepage surfaces these category labels directly on each featured profile:
| Category | Example profile shown |
|---|---|
| Recovery | BPC-157, TB-500 |
| Weight Loss | Semaglutide, Tirzepatide, Retatrutide |
| Skin & Beauty | GHK-Cu |
| Muscle & Growth | CJC-1295, Ipamorelin |
| Longevity | MOTS-c |
| Immune | Thymosin Alpha-1 |
Other categories listed in the site's navigation include Other, GH Secretagogues, and Nootropic Peptides.
Browsing via editorial hubs
Hubs group profiles by mechanism or research area rather than a single use case. Each hub shows a profile count so you can gauge how much material sits behind it:
- GLP-1 Peptides — 29 profiles (semaglutide, tirzepatide, liraglutide, dulaglutide, and more), compared by mechanism, FDA status, and clinical evidence
- Recovery Peptides — 9 profiles
- Longevity Peptides — 23 profiles
- GH Secretagogues — 27 profiles
- Nootropic Peptides — 25 profiles
- Skin Peptides — 23 profiles
- Immune Peptides — 24 profiles
If your question is "which peptides do X," a hub is usually the faster entry point than a single category, because it spans related compounds across mechanisms.
Priority research paths
The homepage also lists curated paths for common research questions, which skip the browsing step entirely:
- GLP-1 peptide hub — class reference
- Best peptides for weight loss — ranking guide
- Tirzepatide profile — dual GLP-1/GIP
- BPC-157 profile — recovery peptide
- Regulatory status tracker — per-compound, sourced
- FDA regulatory timeline — 2023 to 2026
Head-to-head comparisons
If you're deciding between two compounds rather than browsing a category, PeptaHub collects direct comparisons in one place:
- BPC-157 vs TB-500 (recovery)
- Semaglutide vs Tirzepatide (GLP-1)
- Retatrutide vs Tirzepatide (GLP-1)
- Survodutide vs Tirzepatide (GLP-1)
- TB-500 vs Thymosin beta-4 (naming)
- BPC-157 vs MGF (recovery)
- TB-500 vs IGF-1 LR3 (recovery)
- Ipamorelin vs Sermorelin (GH)
What each profile contains
Profiles are described as evidence-based, with mechanisms, research context, risks, and regulatory status, and cite peer-reviewed sources — for example, BPC-157 lists 7 peer-reviewed sources, TB-500 lists 6, and semaglutide lists 5. Source counts vary by compound, so treat them as a rough signal of how much literature the entry draws on, not a quality ranking.
Practical entry points
- Know the use case → pick the category (Recovery, Weight Loss, etc.)
- Know the mechanism class → pick the hub (GLP-1, GH Secretagogues, etc.)
- Comparing two compounds → use the head-to-head comparison list
- Want everything → "Browse all 156 profiles" or "Explore categories"
One caveat: the site presents itself as a reference compendium, and the regulatory tracker and FDA timeline reflect status as documented per compound. Check the individual profile for the current regulatory entry rather than assuming a category-wide status.